Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateWages, Salaries and Other
Others
Ratios

Bicycle Therapeutics (BCYC) Interest Expenses (2021 - 2025)

Bicycle Therapeutics (BCYC) has disclosed Interest Expenses for 5 consecutive years, with $44000.0 as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Interest Expenses rose 33.33% year-over-year to $44000.0, compared with a TTM value of $201000.0 through Sep 2025, down 91.95%, and an annual FY2024 reading of $1.7 million, down 46.98% over the prior year.
  • Interest Expenses was $44000.0 for Q3 2025 at Bicycle Therapeutics, down from $54000.0 in the prior quarter.
  • Across five years, Interest Expenses topped out at $883000.0 in Q2 2022 and bottomed at $33000.0 in Q3 2024.
  • Average Interest Expenses over 5 years is $603684.2, with a median of $818000.0 recorded in 2022.
  • The sharpest move saw Interest Expenses surged 56.7% in 2022, then plummeted 95.95% in 2024.
  • Year by year, Interest Expenses stood at $820000.0 in 2021, then rose by 0.73% to $826000.0 in 2022, then dropped by 0.73% to $820000.0 in 2023, then crashed by 93.66% to $52000.0 in 2024, then dropped by 15.38% to $44000.0 in 2025.
  • Business Quant data shows Interest Expenses for BCYC at $44000.0 in Q3 2025, $54000.0 in Q2 2025, and $51000.0 in Q1 2025.